top of page
The Athena TeamThe Athena Team

The Athena Team

Writer
More actions

Profile

Join date: Apr 17, 2026

Posts (6)

Aug 4, 20266 min
Androgenic Alopecia and Exosome Scalp Therapy: P198
Androgenic alopecia affects up to 50% of men and 40% of women over their lifetimes — yet the clinical options available to practitioners have changed little in decades. Exosome-based scalp therapy represents a meaningful shift in how we approach this condition at the follicular level. For aesthetic clinicians, hair loss is no longer a condition to refer elsewhere. As patients seek non-invasive, science-backed solutions beyond finasteride and minoxidil, the demand for in-clinic hair...

5
0
Jun 19, 20264 min
Why Particle Size Matters: How Smaller Exosomes May Improve Skin Penetration | P198 ExoHealer
When clinics compare exosome skin boosters, the conversation usually starts and ends with growth factor counts or stem cell origin claims. One of the most clinically meaningful — and most overlooked — specifications is something far more measurable: particle size. It's also one of the reasons P198 ExoHealer™ is formulated the way it is. A growth factor figure printed on a spec sheet tells you almost nothing on its own. What matters is whether the particles carrying those growth factors are...

6
0
Jun 19, 20265 min
Beyond PRP: What Is Photothermal Biomodulation and Why It Changes the Regenerative Game [MCT PRP Therapy]
Platelet-rich plasma has been a mainstay of regenerative esthetics for over two decades. Australian and New Zealand clinics have adopted it widely — for skin rejuvenation, hair restoration, and a growing range of dermatological applications. The evidence base is solid, the safety profile is well established, and the autologous nature of the treatment aligns with patient demand for biologics over synthetics. But PRP has a well-documented ceiling. Growth factors degrade rapidly. Preparation...

43
0
bottom of page